CareDx, Inc. (CDNA)
69.09
-0.12
(-0.17%)
USD |
NASDAQ |
Oct 26, 16:00
69.61
+0.52
(+0.75%)
After-Hours: 18:06
CareDx Net Income (TTM) : 111.01M for June 30, 2026
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 111.01M |
| March 31, 2026 | -8.192M |
| December 31, 2025 | -21.35M |
| September 30, 2025 | 70.45M |
| June 30, 2025 | 58.14M |
| March 31, 2025 | 62.08M |
| December 31, 2024 | 52.55M |
| September 30, 2024 | -153.24M |
| June 30, 2024 | -166.09M |
| March 31, 2024 | -186.42M |
| December 31, 2023 | -190.28M |
| September 30, 2023 | -90.52M |
| June 30, 2023 | -83.97M |
| March 31, 2023 | -80.71M |
| December 31, 2022 | -76.61M |
| September 30, 2022 | -74.44M |
| June 30, 2022 | -69.39M |
| March 31, 2022 | -49.62M |
| December 31, 2021 | -30.66M |
| September 30, 2021 | -18.03M |
| June 30, 2021 | -8.947M |
| March 31, 2021 | -13.58M |
| December 31, 2020 | -18.71M |
| September 30, 2020 | -19.98M |
| June 30, 2020 | -18.97M |
| Date | Value |
|---|---|
| March 31, 2020 | -20.26M |
| December 31, 2019 | -21.97M |
| September 30, 2019 | -20.95M |
| June 30, 2019 | -39.10M |
| March 31, 2019 | -45.32M |
| December 31, 2018 | -46.78M |
| September 30, 2018 | -74.66M |
| June 30, 2018 | -68.97M |
| March 31, 2018 | -58.94M |
| December 31, 2017 | -55.56M |
| September 30, 2017 | -39.64M |
| June 30, 2017 | -29.15M |
| March 31, 2017 | -35.61M |
| December 31, 2016 | -39.75M |
| September 30, 2016 | -28.81M |
| June 30, 2016 | -28.50M |
| March 31, 2016 | -21.19M |
| December 31, 2015 | -13.71M |
| September 30, 2015 | -8.951M |
| June 30, 2015 | -4.249M |
| March 31, 2015 | -0.187M |
| December 31, 2014 | 0.781M |
| September 30, 2014 | -0.016M |
| June 30, 2014 | -2.577M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Natera, Inc. | -192.35M |
| Caris Life Sciences, Inc. | 105.14M |
| Myriad Genetics, Inc. | -112.60M |
| BioRestorative Therapies, Inc. | -11.06M |
| Exagen, Inc. | -18.92M |